Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
Condition: Venous Thromboembolism Interventions: Drug: Rivaroxaban; Drug: Warfarin; Drug: Nadroparin Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University; Sir Run Run Shaw Hospital; Huadong Hospital; Shanghai Zhongshan Hospital; Shanghai 5th People's Hospital; Yantai Yuhuangding Hospital; Anhui Provincial Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials